Corporate highlights

$
287
M
total raised
$
1.1
B
total partnership value*
2 IND
S
planned by 2025

Scientific highlights

> TB
proprietary data generated
> M
cells imaged
> K
compound chemical library
*excluding royalties

Corporate documents

Video

 
Learn how Dewpoint leverages condensate biology to expand the druggable target space to address diseases of high unmet need.
 
Our founders and advisors explain how condensates drive cell function

Current investors

Key links

To know more about the science of condensates:

Contact us

Contact Investor Relations directly by email: ir@dewpointx.com

Subscribe to receive Dewpoint information:

Follow us

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science